| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 12/18/2003 | WO2001034829A3 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
| 12/18/2003 | US20030233681 ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 12/18/2003 | US20030232975 Comprises nucleotide sequences coding polypeptides for diagnosing, preventing and treating cancer |
| 12/18/2003 | US20030232414 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 12/18/2003 | US20030232413 Transformed fungi for production of recombinant proteins |
| 12/18/2003 | US20030232362 A protein which excretes cancer chemotherapeutic drugs from a cell and which confers drug- resistance on the cell, a DNA encoding the protein, a method for detecting a cell type resistant to cancer chemotherapeutic drugs |
| 12/18/2003 | US20030232350 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 12/18/2003 | US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders |
| 12/18/2003 | US20030232339 Human TRPCC cation channel and uses |
| 12/18/2003 | US20030232054 Novel nucleic acids and polypeptides |
| 12/18/2003 | US20030232035 Capable of expressing a heterologous sequence in target cells; vaccines |
| 12/18/2003 | US20030232009 Used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes |
| 12/18/2003 | DE20307444U1 Vorrichtung zur biotechnologischen Herstellung von Wertstoffen Device for the biotechnological production of useful materials |
| 12/18/2003 | CA2489180A1 Method for mapping and eliminating t-cell epitopes |
| 12/18/2003 | CA2488773A1 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
| 12/18/2003 | CA2487077A1 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 12/18/2003 | CA2486362A1 Novel recombinant anticoagulant proteins |
| 12/17/2003 | EP1371734A1 Method of deamidation of milk protein and method of denaturation of milk protein |
| 12/17/2003 | EP1371728A1 Gene encoding adseverin |
| 12/17/2003 | EP1370696A2 Expression profiles and methods of use |
| 12/17/2003 | EP1370676A2 Mouse cytokine receptor |
| 12/17/2003 | EP1370674A2 Enzymes having alpha amylase activity and methods of use thereof |
| 12/17/2003 | EP1370664A2 Nucleic acid which is stabilised against decomposition |
| 12/17/2003 | EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 12/17/2003 | EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same |
| 12/17/2003 | EP1370655A2 Secreted human proteins |
| 12/17/2003 | EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins |
| 12/17/2003 | EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 12/17/2003 | EP1370583A1 Polypeptides and nucleic acids for bolekine |
| 12/17/2003 | EP1370580A2 A new essential downstream component of the wingless signalling pathway |
| 12/17/2003 | EP1370575A2 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/17/2003 | EP1370571A2 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefor |
| 12/17/2003 | EP1007074B1 Hypothalamus-specific polypeptides |
| 12/17/2003 | EP0954580B1 Human sdf-5 protein and compositions |
| 12/17/2003 | EP0805867B1 Dna integration by transposition |
| 12/17/2003 | EP0795005B1 New e.coli mutant with suppressed organic acid production |
| 12/17/2003 | EP0792363B1 Novel pesticidal proteins and strains |
| 12/17/2003 | EP0763101B1 Nucleic acid sequences and expression systems for heparinase iii derived from flavobacterium heparinum |
| 12/17/2003 | EP0690132B1 Anti-hiv monoclonal antibody |
| 12/17/2003 | EP0672131B1 A novel cell cycle control protein |
| 12/17/2003 | EP0650523B1 RECOMBINANT CDw52 ANTIGEN |
| 12/17/2003 | EP0571387B1 A non-mitogenic competitive hgf antagonist |
| 12/17/2003 | EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 12/17/2003 | EP0527753B2 Purification and use of pertactin, a bordetella pertussis outer membrane protein |
| 12/17/2003 | EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor |
| 12/17/2003 | CN1131313C Promoters for gene expression |
| 12/17/2003 | CN1131312C N-teminally extended proteins expressed in yeast |
| 12/17/2003 | CN1131309C IL-6 mutein |
| 12/16/2003 | US6664385 Kidney injury-related molecules |
| 12/16/2003 | US6664376 Chimeric polypeptide molecules |
| 12/16/2003 | US6664375 Nucleotide sequences coding binding protein for use in the treatment of alzheimer's disease and nervous system disorders |
| 12/16/2003 | US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 12/16/2003 | US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 12/16/2003 | US6664098 Cellular differentiation and proliferation; ligands, membrane receptors; antigrowth agents; use of human Notch ligand, human Delta molecule, in development of drug candidates for differential regulation of undifferentiated cells |
| 12/16/2003 | US6664092 Nucleic acid sequences; amino acid sequences; vectors; host cells; genetic engineering; Aspergillus oryzae; use in the production of protein hydrolysates having desirable organoleptic properties and high degrees of hydrolysis |
| 12/16/2003 | US6664087 Isolated human kinase proteins |
| 12/16/2003 | US6663873 Antigenic preparation for treatment or prevention of helicobacter infection |
| 12/16/2003 | US6663872 Immune response |
| 12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
| 12/16/2003 | US6663867 Administering to a patient a hybrid protein comprising two different coexpressed amino acid sequences forming heterodimer, each comprising an amino acid sequence of tumor nacrosis factor binding protein and a subunit of hCG, FSG, LH |
| 12/16/2003 | CA2134751C Monoclonal antibodies and their use |
| 12/16/2003 | CA2096604C Protein c derivatives |
| 12/16/2003 | CA2072627C Recombinant herpes simplex viruses vaccines and methods |
| 12/11/2003 | WO2003102201A2 Methods and materials for the production of d-lactic acid in yeast |
| 12/11/2003 | WO2003102200A2 Fermentation process using specific oxygen uptake rates as a process control |
| 12/11/2003 | WO2003102196A1 Vectors for expression of biotinylated proteins in mammalian cells, and their use for identification of protein-nucleic acid interactions in vivo |
| 12/11/2003 | WO2003102195A1 Protein hydrolysate rich in tripeptides |
| 12/11/2003 | WO2003102189A1 Allergen from mugwort pollen |
| 12/11/2003 | WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 12/11/2003 | WO2003102182A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| 12/11/2003 | WO2003102166A2 Novel flavivirus antigens |
| 12/11/2003 | WO2003102152A2 Methods and materials for the production of lactic acid in yeast |
| 12/11/2003 | WO2003102143A2 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1) |
| 12/11/2003 | WO2003102138A2 Elongase genes and uses thereof |
| 12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
| 12/11/2003 | WO2003102029A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003101485A1 Cd16a binding proteins and use for the treatment of immune disorders |
| 12/11/2003 | WO2003091404A3 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 12/11/2003 | WO2003074670A3 Lis promoter for expression of transgenes in floral tissues |
| 12/11/2003 | WO2003066864A3 Method for predicting the expression efficiency in cell-free expression systems |
| 12/11/2003 | WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 12/11/2003 | WO2003057138A3 Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase |
| 12/11/2003 | WO2003050274A3 Process for harvesting crystalline particles from fermentation broth |
| 12/11/2003 | WO2003048306A3 Polycistronic expression of antibodies |
| 12/11/2003 | WO2003044048A3 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen |
| 12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
| 12/11/2003 | WO2003029458A3 Method for producing protein libraries and for selecting proteins from said libraries |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens |
| 12/11/2003 | WO2003012451A3 Methods for detecting of intermoleculair interactions using protein arrays |
| 12/11/2003 | WO2003001882A3 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002075507B1 Anti-bacterial vaccine compositions |
| 12/11/2003 | WO2002072013A3 Method of treating malignancies through induction of blood immune responses |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | US20030229215 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides |